Pei-Yong Shi, the John Sealy Distinguished Chair in Innovations in Molecular Biology at the University of Texas Medical Branch, works on RNA virus, drug discovery, and vaccine research. He has experience in both basic and translational research in a career that has spanned public health, industry, and academia. In his keynote, “SARS-CoV-2 Biology and countermeasure development,” he talks about efforts to understand how mutations found in emerging coronavirus variants impact the virulence, transmissibility and biology of the coronavirus behind the global pandemic. Part of the NIBR Science of Therapeutics Symposium on Coronavirus Antivirals, June 8, 2021. Content presented by external speakers not affiliated with Novartis are responsible for their own content and do not speak on behalf of Novartis. Learn more: https://bit.ly/3kSCJBe ©2021 Novartis AG

 1627      11